Key facts
- This page summarizes Kevin Walter Collins's Form 4 filing for Lucira Health, Inc..
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 13 Mar 2023, 17:09.
Kevin Walter Collins - 03 Mar 2023 Form 4 Insider Report for Lucira Health, Inc.
- Reporting relationship
- Chief Revenue Officer
- Issuer ticker
- N/A
- Reported as of
- 03 Mar 2023
- Net transaction value
- -$73,841
- SEC form
- 4
- Accepted by SEC
- 13 Mar 2023, 17:09:40 UTC
- Prior SEC filing
- 29 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Richard Narido, Attorney-In-Fact for Kevin Collins
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kevin Walter Collins filed Form 4 for Lucira Health, Inc. on 13 Mar 2023.
Change
- Previous filing in this sequence was filed on 29 Nov 2022.
- Current net transaction value: -$73,841.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LHDXQ
transaction
Common Stock
Sale
- Transaction value
- $34,617
- Shares
- -30,102
- Change %
- -8.7%
- Price
- $1.15*
- Shares after
- 316,620
- Date
- 03 Mar 2023
- Ownership
- Direct
LHDXQ
transaction
Common Stock
Sale
- Transaction value
- $39,224
- Shares
- -81,717
- Change %
- -26%
- Price
- $0.4800*
- Shares after
- 234,903
- Date
- 07 Mar 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.